Pharmaresearch Bio Co (XKRX:217950) Gross-Profit-to-Asset % : 20.12% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Pharmaresearch Bio Co's annualized Gross Profit for the quarter that ended in Dec. 2023 was ₩12,355 Mil. Pharmaresearch Bio Co's average Total Assets over the quarter that ended in Dec. 2023 was ₩61,415 Mil. Therefore, Pharmaresearch Bio Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 20.12%.

Pharmaresearch Bio Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Pharmaresearch Bio Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Gross-Profit-to-Asset % Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

11.12

14.04

15.95

12.57

20.12

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			11.12	14.04	15.95	12.57	20.12

Competitive Comparison of Pharmaresearch Bio Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Pharmaresearch Bio Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaresearch Bio Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's Gross-Profit-to-Asset % falls into.

Pharmaresearch Bio Co Gross-Profit-to-Asset % Calculation

Pharmaresearch Bio Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	12354.549	/	( (58905.474	+	63924.953)	/ 2 )
	=	12354.549	/	61415.2135
	=	20.12 %

Pharmaresearch Bio Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	12354.549	/	( (58905.474	+	63924.953)	/ 2 )
	=	12354.549	/	61415.2135
	=	20.12 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Pharmaresearch Bio Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co (XKRX:217950) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines